Clinical Trial Update: Atripla to Stribild Switch Study to Evaluate Sleep Disturbances [Phase 4]

View source ↗

Summary

This Phase 4 switch study evaluated sleep disturbances when moving from Atripla to Stribild in people with HIV/AIDS, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Sponsor: Midtown Medical Center, Tampa, FL | Conditions: HIV, AIDS | Phase 4 | Status: COMPLETED | Results posted: 2017-07-02